Sippican Capital Advisors Takeda Pharmaceutical CO LTD Transaction History

Sippican Capital Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$15.03 - $16.32 $1.05 Million - $1.14 Million	-70,115 Reduced 86.78%	10,684 $165,000
Q2 2023 Aug 15, 2023	SELL	$15.57 - $17.11 $22,358 - $24,569	-1,436 Reduced 1.75%	80,799 $1.27 Million
Q4 2022 Jan 26, 2023	SELL	$12.42 - $15.62 $64,894 - $81,614	-5,225 Reduced 5.97%	82,235 $0
Q3 2022 Oct 17, 2022	BUY	$12.8 - $28.65 $18,112 - $40,539	1,415 Added 1.64%	87,460 $1.13 Million
Q2 2022 Jul 19, 2022	BUY	$13.12 - $15.03 $72,881 - $83,491	5,555 Added 6.9%	86,045 $1.21 Million
Q1 2022 Apr 20, 2022	BUY	$13.54 - $15.35 $148,127 - $167,929	10,940 Added 15.73%	80,490 $1.15 Million
Q4 2021 Jan 19, 2022	BUY	$13.17 - $16.4 $345,449 - $430,171	26,230 Added 60.55%	69,550 $948,000
Q3 2021 Oct 20, 2021	BUY	$16.3 - $17.26 $539,693 - $571,478	33,110 Added 324.29%	43,320 $710,000
Q2 2021 Jul 22, 2021	BUY	$16.55 - $18.64 $168,975 - $190,314	10,210 New	10,210 $172,000

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Sippican Capital Advisors, based on Form 13F filings with the SEC.

Stay updated on Sippican Capital Advisors with notifications on news.